Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARĪ³ agonist treatment
Crossref DOI link: https://doi.org/10.1007/s00125-016-4130-1
Published Online: 2016-10-07
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Kai
Park, Jiyoung
Kim, Min
Scherer, Philipp E.
License valid from 2016-10-07
